The use of cyclosporin-A in the treatment of B-chronic lymphocytic leukemia.
Emilia
G
G
Messora
C
C
Bensi
L
L
D000744:Anemia, Hemolytic, Autoimmune / Q000097:blood / Q000188:drug therapy* / Q000209:etiology; D001327:Autoimmune Diseases / Q000097:blood / Q000188:drug therapy* / Q000209:etiology; D016572:Cyclosporine / Q000627:therapeutic use*; D018450:Disease Progression; D004351:Drug Resistance; D017809:Fatal Outcome; D005260:Female; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D007376:Interleukin-2 / Q000494:pharmacology; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000150:complications / Q000473:pathology / Q000628:therapy*; D016393:Lymphoma, B-Cell / Q000188:drug therapy / Q000473:pathology; D008875:Middle Aged; D014411:Neoplastic Stem Cells / Q000187:drug effects; D011994:Recombinant Proteins / Q000494:pharmacology
D006454:Hemoglobins; D007376:Interleukin-2; D011994:Recombinant Proteins; D016572:Cyclosporine